Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 8;13(1):66.
doi: 10.1186/s13293-022-00468-6.

Sex differences in the medial prefrontal cortical glutamate system

Affiliations

Sex differences in the medial prefrontal cortical glutamate system

Melissa C Knouse et al. Biol Sex Differ. .

Abstract

Background: Dysregulation in the prefrontal cortex underlies a variety of psychiatric illnesses, including substance use disorder, depression, and anxiety. Despite the established sex differences in prevalence and presentation of these illnesses, the neural mechanisms driving these differences are largely unexplored. Here, we investigate potential sex differences in glutamatergic transmission within the medial prefrontal cortex (mPFC). The goal of these experiments was to determine if there are baseline sex differences in transmission within this region that may underlie sex differences in diseases that involve dysregulation in the prefrontal cortex.

Methods: Adult male and female C57Bl/6J mice were used for all experiments. Mice were killed and bilateral tissue samples were taken from the medial prefrontal cortex for western blotting. Both synaptosomal and total GluA1 and GluA2 levels were measured. In a second set of experiments, mice were killed and ex vivo slice electrophysiology was performed on prepared tissue from the medial prefrontal cortex. Spontaneous excitatory postsynaptic currents and rectification indices were measured.

Results: Females exhibit higher levels of synaptosomal GluA1 and GluA2 in the mPFC compared to males. Despite similar trends, no statistically significant differences are seen in total levels of GluA1 and GluA2. Females also exhibit both a higher amplitude and higher frequency of spontaneous excitatory postsynaptic currents and greater inward rectification in the mPFC compared to males.

Conclusions: Overall, we conclude that there are sex differences in glutamatergic transmission in the mPFC. Our data suggest that females have higher levels of glutamatergic transmission in this region. This provides evidence that the development of sex-specific pharmacotherapies for various psychiatric diseases is important to create more effective treatments.

Keywords: AMPA receptors; Excitatory transmission; Glutamate; Medial prefrontal cortex; Sex differences.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Female mice exhibit higher levels of synaptosomal GluA1 and GluA2 expression in the mPFC compared to male mice. Western blotting revealed higher levels of synaptosomal GluA1 in the mPFC of females compared to males (A; n = 5–7/group). However, there are no significant differences between females and males in total levels of GluA1 (B; n = 3/group). We also found females exhibit higher levels of synaptosomal GluA2 in the mPFC compared to males (C; n = 6/group). Again, these differences are not present in total GluA2, where males and females do not exhibit significant differences (D; n = 6–7/group)
Fig. 2
Fig. 2
Female mice have enhanced glutamatergic transmission in the mPFC compared to male mice. Whole-cell recordings demonstrate females have heightened sEPSC amplitude (A; n = 9–14/group) and a rightward shift in the cumulative probability distribution (B) compared to males. Females also exhibit heightened sEPSC frequency (C; n = 9–14/group) and a leftward shift in the cumulative probability distribution of inter-event intervals (D) compared to males. Females also exhibit a larger rectification index compared to males (E; n = 9–11/group). Example electrode placement in the mPFC and representative traces for sEPSC and rectification recordings (F)

References

    1. Steketee JD. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res Brain Res Rev. 2003;41(2–3):203–228. doi: 10.1016/s0165-0173(02)00233-3. - DOI - PubMed
    1. Szczepanski SM, Knight RT. Insights into human behavior from lesions to the prefrontal cortex. Neuron. 2014;83(5):1002–1018. doi: 10.1016/j.neuron.2014.08.011. - DOI - PMC - PubMed
    1. Riga D, Matos MR, Glas A, Smit AB, Spijker S, Van den Oever MC. Optogenetic dissection of medial prefrontal cortex circuitry. Front Syst Neurosci. 2014;8:230. doi: 10.3389/fnsys.2014.00230. - DOI - PMC - PubMed
    1. Xu P, Chen A, Li Y, Xing X, Lu H. Medial prefrontal cortex in neurological diseases. Physiol Genomics. 2019;51(9):432–442. doi: 10.1152/physiolgenomics.00006.2019. - DOI - PMC - PubMed
    1. Hare BD, Duman RS. Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions. Mol Psychiatry. 2020;25(11):2742–2758. doi: 10.1038/s41380-020-0685-9. - DOI - PMC - PubMed

Publication types

LinkOut - more resources